5 October 2024
Hogan Lovells advises Recordati on the acquisition of Enjaymo® for a consideration of US$825 million plus additional commercial milestone payments of up to US$250 million
Advising firms
Deal team
9 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Francesco Stella Lead | Hogan Lovells Cadwalader | Partner | Mergers & Acquisitions | Milan |
| Mahvesh Qureshi | Hogan Lovells Cadwalader | Partner | Mergers & Acquisitions | Washington, D.C. |
| Gabrielle Witt | Hogan Lovells Cadwalader | Partner | Mergers & Acquisitions | Washington, D.C. |
| Derrik Forshee | Hogan Lovells Cadwalader | Partner | Mergers & Acquisitions | Baltimore |
| Penny Powell | Hogan Lovells Cadwalader | Partner | Strategic Operations, Agreements and Regulation (SOAR) | London |
| Julia Wahl | Hogan Lovells Cadwalader | Senior associate | Mergers & Acquisitions | Washington, D.C. |
| Samantha Seiden | Hogan Lovells Cadwalader | Senior associate | Mergers & Acquisitions | Los Angeles |
| Marina Massaro | Hogan Lovells Cadwalader | Associate | Private Equity Transactions | Milan |
| Bea Watts | Hogan Lovells Cadwalader | Not stated | Pharmaceuticals & Biotechnology | London |
6 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 825m (US$825 million)
- What the figure measures
- Total transaction value
- Client
- RecordatiBuy-side
- Counterparties
- Sanofi (Sell-side)